1997
DOI: 10.1128/jvi.71.5.3840-3852.1997
|View full text |Cite
|
Sign up to set email alerts
|

Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process

Abstract: Equine infectious anemia virus (EIAV) provides a natural model system by which immunological control of lentivirus infections may be studied. To date, no detailed study addressing in parallel both the humoral and cellular immune responses induced in horses upon infection by EIAV has been conducted. Therefore, we initiated the first comprehensive characterization of the cellular and humoral immune responses during clinical progression from chronic disease to inapparent stages of EIAV infection. Using new analys… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

7
58
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 142 publications
(65 citation statements)
references
References 59 publications
7
58
0
Order By: Relevance
“…The virus neutralizing (VN) antibodies have a crucial role in prevention of disease caused by Equine Arteritis Virus (EAV) in horses [32] and Lactate dehydrogenaseelevating virus (LDV) in mice [33]. Similarly, inhibition of the PRRSV replication can be achieved by VN antibodies [34].…”
Section: Discussionmentioning
confidence: 99%
“…The virus neutralizing (VN) antibodies have a crucial role in prevention of disease caused by Equine Arteritis Virus (EAV) in horses [32] and Lactate dehydrogenaseelevating virus (LDV) in mice [33]. Similarly, inhibition of the PRRSV replication can be achieved by VN antibodies [34].…”
Section: Discussionmentioning
confidence: 99%
“…Serum immunoglobulin G antibody reactivity to EIAV FDDV envelope glycoprotein was quantitatively (endpoint titer) and qualitatively (avidity index and conformation ratio) assayed using a standard ConA ELISA procedure as previously described (9), except that the coated EIAV PV was replaced with gradient-purified EIAV FDDV . The end-point titer of core p26-specific IgG was detected using a standard ELISA.…”
Section: Quantitative and Qualitative Serological Assaysmentioning
confidence: 99%
“…All of the sera were heat inactivated (56°C for 30 min) before the neutralization assay to inactivate infectious virus and labile serum proteins. The serum neutralizing activity against homologous (pLGFD3V), or relatively heterologous (pLGFD3Mu12V) virus strains, was assessed with a modified indirect cell ELISA-based infectious center assay method using a constant amount of pLGFD3V or pLGFD3Mu12V, and sequential twofold dilutions of serum, as previously described (9). The serum neutralizing activity against DLV34 was assessed with an RT assay as previously described (19).…”
Section: Neutralizing Antibody Assaymentioning
confidence: 99%
“…Interestingly, while neutralizing antibody titers to the homologous virus emerge rapidly after infection, it is not until this antibody maturation is achieved that emergence of neutralizing antibody responses to the heterologous challenge virus is evident [8]. Furthermore, studies in the HIV-1 [10], SHIV [10] and equine infectious anemia virus (EIAV) [24] systems suggest that this antibody maturation process is a common property of lentiviruses [36].…”
Section: Introductionmentioning
confidence: 99%